GSK
Director, Manufacturing Sciences & Technology
Mark brings over a decade of valuable experience in pharmaceutical manufacturing and development to his current role as Site MSAT Director at GSK. In this capacity, he is responsible for nurturing the talent, culture, and technical expertise of an MSAT organization critical to the successful introduction of new products and the ownership of the latest technical standards, ultimately ensuring reliable patient supply.
Mark is a visionary leader who champions the integration of talented people, lean thinking, and cutting-edge technologies to drive innovation in the manufacturing of life-changing medicines. His commitment to continuous improvement is underpinned by his Six Sigma Black Belt certification and a passion for coaching, fostering effective teams, and solving complex problems.
Prior to joining GSK, Mark made significant contributions at AstraZeneca, where he built the teams and capabilities necessary for the seamless transition of two advanced aseptic syringe filling and assembly assets from engineering to operational readiness, ensuring cGMP compliance and readiness for commercial supply. Earlier in his career, as Global Technical Manager for Validation Sciences, he led the global strategy for Continued Process Verification (CPV) and Process Intelligence data strategy, alongside authoring cross-functional quality standards for the Process Validation lifecycle.
Mark's academic credentials include an MSc in Analytical Science from Kings College London and a BSc in Chemistry from National University of Ireland, Galway. A dedicated and engaged member of ISPE, Mark actively volunteers his expertise, frequently presents at industry events, contributes to the development of guidelines, co-chairs technical committees, and has served on the organizing committee for the ISPE annual meeting.